Ophthalmic Drugs Market Size, Shares, Growth, Segments, Industry Analysis & Outlook 2017-2023

1
Ophthalmic Drugs Market Global Industry
Analysis, Trends, Market Size and Forecasts up to
2023
2
A latest report has been added to the wide
database of Ophthalmic Drugs Market by Infinium
Global Research. This report studies the
Ophthalmic Drugs Market by disease condition
(allergy, glaucoma, dry eye disorder and retinal
disorder), dispenses type (prescription and over
the counter) market status and outlook of global
and major regions, from manufacturers, and end
industries. The objective of the study is to
identify market sizes of different segments
countries in recent years and to forecast the
values for the next six years. Ophthalmic Drugs
Market provides opportunities in micro markets
for stakeholders to invest along with the
detailed analysis of competitive landscape,
latest trends, and product offerings of the major
companies in the Ophthalmic Drugs Market.
According to report the global ophthalmic drugs
market is projected to grow at a CAGR of 5.4
over the forecast period of 2017-2023. Ophthalmic
drugs are the drugs designed for the treatment of
eye diseases and disorders. This administration
of drug can be done by instillation of a cream,
an ointment, or a liquid drop preparation in the
conjunctiva SAC. The correct strength and amount
of the drug are selected, and the medication is
instilled into the eye or eyes as directed. The
main reason of continuingly strong interest of
scientists in these drugs forms is the problem of
a low bioavailability of medicinal substance
after the application to the eyeball. The
ability to increase the bioavailability of the
active substances, reducing the susceptibility of
drug forms to defense mechanisms of the human
eye, extending contact time of drug with the
cornea, increasing the penetration through the
complex anatomical structure of the eye, and
providing controlled release of drugs into the
eye tissues which allows reducing the drug
application frequency, witnesses the importance
of ophthalmic drugs among the aging population
suffering from eye disorders are some of the
factors contributing to the growth in the global
ophthalmic drugs market. Market Insights The key
factors driving the growth of ophthalmic drugs
market are considered to be increasing geriatric
population with rising global population,
increase in prevalence of eye disorders,
technological advancement, and increasing
awareness in healthcare spending. Moreover,
challenges faced by ophthalmic drugs market
include absence of health insurance in developing
countries regarding eye diseases and lack of
awareness among the people regarding eye diseases
and disorders in underdeveloped and developing
countries. One of the key opportunities for new
entrants is securing drugs through a licensing
agreement with major players such as novartis and
bayer, which could boost their growth over the
forecast period. Make an Enquiry -
https//www.infiniumglobalresearch.com/Reports/Mak
eEnquiryRequest/165
3
Segment Covered The report on global ophthalmic
drugs market covers segments such as, disease
condition and dispenses type. On the basis of
disease condition the global ophthalmic drugs
market is categorized into allergy, glaucoma, dry
eye disorder and retinal disorder. On the basis
of dispense type the global ophthalmic drugs
market is categorized into prescription and over
the counter. Geographic Coverage The report
provides regional analysis covering geographies
such as North America, Europe, Asia-Pacific, and
Rest of the World. In this section the key
trends and market size for each geography is
provided over the period of 2015-2023. The
countries covered in the North America region
include the U.S., Canada, and Mexico while
Asia-Pacific includes China, Japan, India, South
Korea, Malaysia, and among others. Moreover,
Germany, U.K., France, Spain, and Rest of Europe
are included in the European region. The U.S.
drives the growth in the North America region as
it is the largest market in the region. The
Asia-pacific region offers a substantial
potential for the market growth owing to rapid
growth in markets such as India and China. The
APAC region is projected to experience a growth
at a CAGR of x.x over the period of
2017-2023. Companies Profiled The report
provides profiles of the companies in the global
ophthalmic drugs market such as, Abbott
Healthcare, Allergan Plc, Johnson Johnson,
Bayer, Valeant Pharmaceuticals, Inc., Pfizer,
Inc., Merck Co., Novartis AG, Renegeron and
Santen Pharmaceuticals Company Ltd. Report
Highlights The report provides deep insights on
demand forecasts, market trends and micro and
macro indicators. In addition, this report
provides insights on the factors that are driving
and restraining the global ophthalmic drugs
market. Moreover, IGR-Growth Matrix analysis
given in the report brings an insight on the
investment areas that existing or new market
players can consider. The report provides
insights into the market using analytical tools
such as Porter's five forces analysis and DRO
analysis of ophthalmic drugs market. Moreover,
the study highlights current market trends and
provides forecast from 2017-2023. We also have
highlighted future trends in the ophthalmic
drugs market that will impact the demand during
the forecast period. Moreover, the competitive
analysis given in each regional market brings an
insight on the market share of the leading
players. This report will help manufacturers,
4

• suppliers and distributors of the ophthalmic
  drugs market to understand the present and future
  trends in this market and formulate their
  strategies accordingly.
• For Sample Pages of this Report
  https//www.infiniumglobalresearch.com/Reports/Mak
  eSampleRequest/165
• Table of Contents-
• Preface
• Report Description
• Research Methods
• Research Approaches
• Executive Summary
• Global Ophthalmic Drugs Market Overview
• Introduction
• Market Dynamics
• Drivers
• Restraints
• Opportunities
• Porter's Five Forces Analysis

5

• 4.4. Retinal Disorder
• Global Ophthalmic Drugs Market by Dispense Type
• Prescription
• Over the Counter
• Global Ophthalmic Drugs Market by Region
  2017-2023
• North America
• North America Ophthalmic Drugs Market by Disease
  Condition
• North America Ophthalmic Drugs Market by Dispense
  Type
• North America Ophthalmic Drugs Market by Country
• Europe
• Europe Ophthalmic Drugs Market by Disease
  Condition
• Europe Ophthalmic Drugs Market by Dispense Type
• Europe Ophthalmic Drugs Market by Country
• Asia-Pacific
• Asia-Pacific Ophthalmic Drugs Market by Disease
  Condition
• Asia-Pacific Ophthalmic Drugs Market by Dispense
  Type
• Asia-Pacific Ophthalmic Drugs Market by Country

6

• Johnson Johnson
• Bayer
• Valeant Pharmaceuticals, Inc.
• Pfizer, Inc.
• Merck Co.
• Novartis AG
• Renegeron
• Santen Pharmaceuticals Company Ltd.
• Click the Below View Full Report -
  https//www.infiniumglobalresearch.com/healthcare_
  medical_devices/global_ophthalmic_drugs_market